共 50 条
Advantage of Log Odds of Metastatic Lymph Nodes After Curative-Intent Resection of Gallbladder Cancer
被引:1
|作者:
Catalano, Giovanni
[1
,2
,3
]
Alaimo, Laura
[1
,2
,3
]
Chatzipanagiotou, Odysseas P.
[1
,2
]
Ruzzenente, Andrea
[3
]
Aucejo, Federico
[4
]
Marques, Hugo P.
[5
]
Bhimani, Nazim
[6
]
Hugh, Tom
[6
]
Maithel, Shishir K.
[7
]
Kitago, Minoru
[8
]
Endo, Itaru
[9
]
Pawlik, Timothy M.
[1
,2
]
机构:
[1] Ohio State Univ, Wexner Med Ctr, Dept Surg, Columbus, OH 43210 USA
[2] James Comprehens Canc Ctr, Columbus, OH 43210 USA
[3] Univ Verona, Dept Surg, Verona, Italy
[4] Cleveland Clin Fdn, Digest Dis & Surg Inst, Dept Hepatopancreatobiliary & Liver Transplant Sur, Cleveland, OH USA
[5] Curry Cabral Hosp, Dept Surg, Lisbon, Portugal
[6] Univ Sydney, Sch Med, Dept Surg, Sydney, NSW, Australia
[7] Emory Univ, Winship Canc Inst, Div Surg Oncol, Atlanta, GA USA
[8] Keio Univ, Dept Surg, Tokyo, Japan
[9] Yokohama City Univ, Sch Med, Yokohama, Japan
关键词:
Gallbladder cancer;
Lymph node;
Metastasis;
Staging;
Surgery;
INTRAHEPATIC CHOLANGIOCARCINOMA;
RADICAL SURGERY;
SURVIVAL;
CARCINOMA;
ADENOCARCINOMA;
HEPATECTOMY;
SUPERIORITY;
PROGNOSIS;
D O I:
10.1245/s10434-024-16492-2
中图分类号:
R73 [肿瘤学];
学科分类号:
100214 ;
摘要:
Background. Lymph node metastasis (LNM) is among the most important predictors of poor prognosis after surgery for gallbladder cancer (GBC). Traditionally, staging has been based on the raw count of LNM, with a high risk of understaging patients who undergo inadequate lymph node dissection (LND). The log odds of metastatic lymph nodes (LODDS) may represent an alternative staging approach to stratify patients more accurately after resection of GBC. Patients and Methods. In this cross-sectional study, patients who underwent curative-intent surgery with LND for GBC were identified from an international database. Two predictive models were built and compared, each integrating a different lymph nodes status indicator [i.e., American Joint Committee on Cancer (AJCC) and LODDS]. Results. Among 199 patients, the median number of lymph nodes examined was 5 [interquartile range (IQR): 3.0, 8.0]; most patients had T1 (n = 26, 13.1%) or T2 (n = 97, 48.7%) disease, and a subset had LNM (n = 87, 44.0%). Multivariable Cox analysis demonstrated LODDS was an independent predictor of overall survival [hazard ratio (HR) 1.84, 95% confidence interval (CI) 1.5-2.3; p < 0.001]. The LODDS model demonstrated better performance compared with a traditional model that utilized the AJCC N category [concordance (C) index: 0.814 versus 0.763; p < 0.001]. Patients classified as high- versus low-risk based on LODDS had much worse overall survival (OS) (4.9% versus 83.7%, respectively; p < 0.001). The LODDS model performance remained high even among patients with inadequate LND (< 6 LN) (C index: 0.87). An online calculator was developed (https://catalano-giovanni.shinyapps.io/LoddsGBC/). Conclusions. A novel prognostic model based on LODDS may overcome the inherent limitations of the current AJCC staging system, reducing understaging among patients with fewer than six total lymph nodes evaluated.
引用
收藏
页码:1742 / 1751
页数:10
相关论文